Charles Given is a Professor in the College of Nursing. His research focuses on the impact of behavioral interventions using randomized clinical trials among patients with chronic diseases, especially cancer.
Dr. Given completed his Ph.D. at Michigan State University and his B.S. and M.S. at the Ohio State University. His primary appointments at MSU were in the College of Human Medicine, Department of Family Medicine.
Dr. Given’s research interests include: design of clinical trials for testing the efficacy of supportive care interventions for the management of symptoms and side effects among solid tumor cancer patients during chemotherapy; delivery mechanisms for testing the interventions included; in-person, automated voice response systems, and text messaging. Costs of implementing interventions compared with outcomes were a part of this program of research. Together with colleagues, Dr. Given conducted a secondary analysis of linked Medicare Medicaid Claim files to explore how race and socioeconomic status influenced treatment and outcomes among cancer patients. Dr. Given had over three decades of continuous funding from the National Institutes of Health, Agency for Healthcare Research and Quality, and the American Cancer Society as well as funding from Michigan Department of Community Health. Currently, Dr. Given is a consultant on multiple NCI-funded projects, including a clinical trial entitled “Enhanced, EHR-facilitated Cancer Symptom Control (E2C2) Pragmatic Clinical Trial.”